[New post] UOBKH: Innovent Biologics – BUY TP HKD95 (Previous HKD80)

alanyeo posted: " Transforming Into Global Innovator With outstanding in-house R&D capabilities and BD efforts, Innovent has built a robust pipeline of both oncology and non-oncology products with 26 drug candidates in different stages of development. It targets " Respond to this post by replying above this line New post on Alpha Edge Investing UOBKH: Innovent Biologics – BUY TP HKD95 (Previous HKD80) by alanyeo Transforming Into Global Innovator With outstanding in-house R&D capabilities and BD efforts, Innovent has built a robust pipeline of both oncology and non-oncology products with 26 drug candidates in different stages of development. It targets to obtain market approval for five more products by 2023 and transform itself into a global biopharmaceutical innovator in the […] Read more of this post This post is ad-supported ​ alanyeo | September 29, 2021 at 4:35 pm | Tags: Innovent Biologics | Categories: Equities - Research Reports by Brokers/ Banks | URL: https://wp.me/p7fA1-4Aw Comment    See all comments    Like Unsubscribe to no longer receive posts from Alpha Edge Investing. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: http://alphaedgeinvesting.com/2021/09/29/uobkh-innovent-biologics-buy-tp-hkd95-previous-hkd80/ Thanks for flying with WordPress.com